In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
High systolic blood pressure is closely tied to cardiovascular risk, especially as people get older
How should these products be used
Safety Tips and Red Flags To reduce the risks associated with online procurement, researchers should follow a strict vetting protocol
primary-cta Customer Experience and Support Patient loyalty to GLP-1 treatment depends heavily on their customer experience
For accurate dosing in your research, a U-100 insulin syringe (typically 1mL, 0.5mL, or 0.3mL) is the standard as its unit markings allow for precise, small-volume measurements